These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 38702897)

  • 1. Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series.
    Kosek S; Burman J; Punga AR
    Brain Behav; 2024 May; 14(5):e3534. PubMed ID: 38702897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paraneoplastic neurologic syndromes: laboratory diagnostics and immunological aspects].
    Hayden Z; Böröcz K; Csizmadia Z; Kellermayer Z; Balogh P; Berki T
    Magy Onkol; 2019 Sep; 63(3):261-267. PubMed ID: 31533147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
    Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
    JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
    Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
    Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of patients with antibody-related autoimmune encephalitis presenting with disorders of consciousness: A prospective cohort study.
    Shan D; Zhang H; Cui L; Chai S; Chen W; Liu G; Tian F; Fan L; Yang L; Zhang Y
    Immun Inflamm Dis; 2024 Sep; 12(9):e70019. PubMed ID: 39315845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
    Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal variation in autoimmune encephalitis: A multi-center retrospective study.
    Lai QL; Cai MT; Zheng Y; Zhang TY; Fang GL; Shen CH; Qiao S; Zhang YX
    J Neuroimmunol; 2021 Oct; 359():577673. PubMed ID: 34333343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological syndromes and potential triggers associated with antibodies to neuronal surface antigens.
    Klein da Costa B; de Oliveira Pinto P; Staub L; Hansel G; Vanik Pinto G; Porcello Schilling L; Rodrigues Dos Passos G; Alves Martins W; Becker J; Machado Castilhos R; Palmini A; Sato DK
    Mult Scler Relat Disord; 2023 Dec; 80():105022. PubMed ID: 37864878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition to autoimmune encephalitis and paraneoplastic neurological syndromes.
    Muñiz-Castrillo S; Honnorat J
    Curr Opin Neurol; 2024 Jun; 37(3):329-337. PubMed ID: 38483154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
    Li TR; Zhang YD; Wang Q; Shao XQ; Li ZM; Lv RJ
    BMC Neurosci; 2020 Mar; 21(1):13. PubMed ID: 32228575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA
    Lamblin F; Kerstens J; Muñiz-Castrillo S; Vogrig A; Goncalves D; Rogemond V; Picard G; Villard M; Pinto AL; Van Coevorden-Hameete MH; De Bruijn MA; De Vries JM; Schreurs M; Tyvaert L; Hopes L; Aupy J; Marchal C; Psimaras D; Kremer L; Bourg V; Antoine JG; Wang A; Kahane P; Demeret S; Ahle G; Sempere VP; Timestit N; Nourredine M; Maureille A; Benaiteau M; Joubert B; Mignot E; Titulaer MJ; Honnorat J
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200229. PubMed ID: 38657198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and long-term outcome of CASPR2 antibody-associated autoimmune encephalitis in children.
    Liao D; Zhu S; Yang L; Zhang C; He F; Yin F; Peng J
    Ital J Pediatr; 2024 Aug; 50(1):158. PubMed ID: 39183357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes expressing neuronal autoantigens induced immune response in antibody-positive autoimmune encephalitis.
    Gu J; Jin T; Li Z; Chen H; Xia H; Xu X; Gui Y
    Mol Immunol; 2021 Mar; 131():164-170. PubMed ID: 33446390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early predictors of new-onset immune-related seizures: a preliminary study.
    Shi X; Cai W; Zhang X; Pan H; Huang C; Wang S; Xu J
    BMC Neurol; 2022 Dec; 22(1):503. PubMed ID: 36581882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Phenomenology of Autoimmune Encephalitis].
    Holle JF; Jessen F; Kuhn J
    Fortschr Neurol Psychiatr; 2016 May; 84(5):271-80. PubMed ID: 27299786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
    Armangue T; Spatola M; Vlagea A; Mattozzi S; Cárceles-Cordon M; Martinez-Heras E; Llufriu S; Muchart J; Erro ME; Abraira L; Moris G; Monros-Giménez L; Corral-Corral Í; Montejo C; Toledo M; Bataller L; Secondi G; Ariño H; Martínez-Hernández E; Juan M; Marcos MA; Alsina L; Saiz A; Rosenfeld MR; Graus F; Dalmau J;
    Lancet Neurol; 2018 Sep; 17(9):760-772. PubMed ID: 30049614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limbic encephalitis associated with anti-NH2-terminal of α-enolase antibodies: A clinical subtype of Hashimoto encephalopathy.
    Kishitani T; Matsunaga A; Ikawa M; Hayashi K; Yamamura O; Hamano T; Watanabe O; Tanaka K; Nakamoto Y; Yoneda M
    Medicine (Baltimore); 2017 Mar; 96(10):e6181. PubMed ID: 28272206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Heterogeneity in Patients with Glutamate Decarboxylase Antibody.
    Huang J; Li H; Zhou R; Huang W; Lin W; Chen T; Long Y
    Neuroimmunomodulation; 2019; 26(5):234-238. PubMed ID: 31661704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
    Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
    Front Immunol; 2021; 12():719432. PubMed ID: 34975832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.